https://www.selleckchem.com/pr....oducts/Bleomycin-sul
The PSTK marker was further validated with western blot analysis using serum samples (n = 6) from ATB patients and LTBI cases during anti-TB drug treatment, and from healthy controls (n = 3). Time-dependent increase of PSTK was found both in ATB and LTBI patients during the course of anti-TB drug treatment, but not in healthy controls. We have demonstrated that PSTK is a potential treatment-monitoring marker for active and latent TB.PURPOSE Diabetic retinal neurodegeneration (DRN) has been demonstrated in eyes of patients with
Like
Comment
Share
